Laure Gossec
Overview
Explore the profile of Laure Gossec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
446
Citations
11931
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abbas N, Hmamouchi I, Kibbi L, Maroof A, Elzorkany B, Abdulateef N, et al.
Rheumatol Int
. 2025 Mar;
45(4):70.
PMID: 40072616
Discordance between physicians and patients in assessing psoriatic arthritis (PsA) activity is common and might impact treatment adherence and decision-making. Cultural and belief systems may influence this discordance. This study...
2.
Couderc M, Lambert C, Hamroun S, Gallot D, Costedoat-Chalumeau N, Gossec L, et al.
BMC Rheumatol
. 2025 Mar;
9(1):30.
PMID: 40069856
Background: Pregnancy may have a beneficial effect on disease activity in rheumatoid arthritis (RA) but the evidence is more conflicting in spondyloarthritis (SpA). The aim of this study was to...
3.
Nash P, Kerschbaumer A, Konzett V, Aletaha D, Dorner T, Fleischmann R, et al.
Ann Rheum Dis
. 2025 Mar;
PMID: 40037995
In light of the introduction of new Janus kinase inhibitors (JAKi), new indications for JAKi and recent safety considerations that have arisen since the preceding consensus statement on JAKi therapy,...
4.
Gladman D, Mease P, Gossec L, Husni M, Gottlieb A, Ink B, et al.
J Rheumatol
. 2025 Feb;
PMID: 39892885
Objective: To assess the longer-term effect of bimekizumab up to 1 year on patient-reported symptoms, health-related quality of life (HRQOL), and work productivity in patients with active PsA who were...
5.
Ruyssen-Witrand A, Brusq C, Masson M, Bongard V, Salliot C, Poiroux L, et al.
Ann Rheum Dis
. 2025 Jan;
84(1):49-59.
PMID: 39874233
Objectives: To compare two strategies-a hydrocortisone replacement strategy and a prednisone tapering strategy-for their success in glucocorticoid discontinuation in patients with rheumatoid arthritis (RA) with low disease activity (LDA). Methods:...
6.
Yazji S, Helliwell P, Balanescu A, Dernis E, Kiltz U, Kalyoncu U, et al.
J Rheumatol
. 2025 Jan;
PMID: 39814446
Objective: The aim of this study was to evaluate whether meeting minimal disease activity (MDA) as measured by the MDA criteria was perceived as good disease control by patients with...
7.
Lopez-Medina C, Gorlier C, Orbai A, Coates L, Kiltz U, Leung Y, et al.
Rheumatology (Oxford)
. 2025 Jan;
PMID: 39752329
Objectives: To explore thresholds for the Psoriatic Arthritis (PsA) Impact of Disease questionnaire (PsAID12) score against disease activity measures in an observational setting, in patients with PsA. Methods: The baseline...
8.
Portier E, Benattar L, Resche-Rigon M, Dougados M, Gossec L, Molto A
RMD Open
. 2024 Dec;
10(4.
PMID: 39710430
Introduction: The study aimed to identify and describe disease activity trajectories over 10 years in patients with recent-onset axial spondyloarthritis (axSpA) and determine their impact on long-term outcomes. Methods: This...
9.
Bibas N, Pignon C, Lopez-Medina C, Gandjbakhch F, Fautrel B, Gossec L
Rheumatology (Oxford)
. 2024 Dec;
PMID: 39705203
Introduction: The specificity of ultrasonography (US) for enthesitis in psoriatic arthritis (PsA) is unclear. The objective was to analyze the specificity of US enthesitis in Mode B and using Power...
10.
Gossec L, Walsh J, Sengupta R, Bushmakin A, Cappelleri J, Yndestad A, et al.
Rheumatol Ther
. 2024 Dec;
12(1):85-98.
PMID: 39671076
Introduction: Fatigue is a key symptom in patients with ankylosing spondylitis (AS). The objective of this analysis was to estimate the median time to initial and stable improvement events in...